Gender moderates the association between 5-HTTLPR and decision-making under ambiguity but not under risk

Scott F Stoltenberg, Joanna M. Vandever

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Decisions made under ambiguity may involve a different genetic architecture than those made under risk. Because gender moderates the effect of genetic polymorphisms on serotonin function and because there are gender differences in decision-making, the present study examined potential gender moderation of associations between polymorphisms in important serotonin system candidate genes (serotonin transporter [SLC6A4] and tryptophan hydroxylase-2 [TPH2]) and performance on a decision-making task (Iowa Gambling Task, IGT) in healthy, adults (N = 188; 62% women). Subjects were genotyped for the well-studied SLC6A4 promoter variant 5-HTTLPR and a TPH2 single nucleotide polymorphism in intron-8 (rs1386438). Genotype at rs1386438 was not associated with performance on the IGT. A significant gender by 5-HTTLPR genotype interaction effect was detected when decision-making was under ambiguity (i.e. the first block of 20 choices), but not under risk (blocks 2-5). Performance on the first block of 20 choices was not correlated with performance on subsequent blocks, supporting the interpretation that early performance on the IGT indexes decision-making under ambiguity, while performance on blocks 2-5 indexes decision-making under risk. These findings suggest that decision-making under ambiguity and risk may have different genetic architectures and that individual differences in decision-making under ambiguity are associated with genetic variation in SLC6A4.

Original languageEnglish (US)
Pages (from-to)423-428
Number of pages6
JournalNeuropharmacology
Volume58
Issue number2
DOIs
StatePublished - Feb 1 2010

Fingerprint

Decision Making
Tryptophan Hydroxylase
Serotonin
Genotype
Serotonin Plasma Membrane Transport Proteins
Genetic Polymorphisms
Individuality
Introns
Single Nucleotide Polymorphism
Genes

Keywords

  • Decision-making
  • Iowa gambling task
  • Serotonin

ASJC Scopus subject areas

  • Pharmacology
  • Cellular and Molecular Neuroscience

Cite this

Gender moderates the association between 5-HTTLPR and decision-making under ambiguity but not under risk. / Stoltenberg, Scott F; Vandever, Joanna M.

In: Neuropharmacology, Vol. 58, No. 2, 01.02.2010, p. 423-428.

Research output: Contribution to journalArticle

@article{583fdf64ee4341008d971729464d597b,
title = "Gender moderates the association between 5-HTTLPR and decision-making under ambiguity but not under risk",
abstract = "Decisions made under ambiguity may involve a different genetic architecture than those made under risk. Because gender moderates the effect of genetic polymorphisms on serotonin function and because there are gender differences in decision-making, the present study examined potential gender moderation of associations between polymorphisms in important serotonin system candidate genes (serotonin transporter [SLC6A4] and tryptophan hydroxylase-2 [TPH2]) and performance on a decision-making task (Iowa Gambling Task, IGT) in healthy, adults (N = 188; 62{\%} women). Subjects were genotyped for the well-studied SLC6A4 promoter variant 5-HTTLPR and a TPH2 single nucleotide polymorphism in intron-8 (rs1386438). Genotype at rs1386438 was not associated with performance on the IGT. A significant gender by 5-HTTLPR genotype interaction effect was detected when decision-making was under ambiguity (i.e. the first block of 20 choices), but not under risk (blocks 2-5). Performance on the first block of 20 choices was not correlated with performance on subsequent blocks, supporting the interpretation that early performance on the IGT indexes decision-making under ambiguity, while performance on blocks 2-5 indexes decision-making under risk. These findings suggest that decision-making under ambiguity and risk may have different genetic architectures and that individual differences in decision-making under ambiguity are associated with genetic variation in SLC6A4.",
keywords = "Decision-making, Iowa gambling task, Serotonin",
author = "Stoltenberg, {Scott F} and Vandever, {Joanna M.}",
year = "2010",
month = "2",
day = "1",
doi = "10.1016/j.neuropharm.2009.09.010",
language = "English (US)",
volume = "58",
pages = "423--428",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Gender moderates the association between 5-HTTLPR and decision-making under ambiguity but not under risk

AU - Stoltenberg, Scott F

AU - Vandever, Joanna M.

PY - 2010/2/1

Y1 - 2010/2/1

N2 - Decisions made under ambiguity may involve a different genetic architecture than those made under risk. Because gender moderates the effect of genetic polymorphisms on serotonin function and because there are gender differences in decision-making, the present study examined potential gender moderation of associations between polymorphisms in important serotonin system candidate genes (serotonin transporter [SLC6A4] and tryptophan hydroxylase-2 [TPH2]) and performance on a decision-making task (Iowa Gambling Task, IGT) in healthy, adults (N = 188; 62% women). Subjects were genotyped for the well-studied SLC6A4 promoter variant 5-HTTLPR and a TPH2 single nucleotide polymorphism in intron-8 (rs1386438). Genotype at rs1386438 was not associated with performance on the IGT. A significant gender by 5-HTTLPR genotype interaction effect was detected when decision-making was under ambiguity (i.e. the first block of 20 choices), but not under risk (blocks 2-5). Performance on the first block of 20 choices was not correlated with performance on subsequent blocks, supporting the interpretation that early performance on the IGT indexes decision-making under ambiguity, while performance on blocks 2-5 indexes decision-making under risk. These findings suggest that decision-making under ambiguity and risk may have different genetic architectures and that individual differences in decision-making under ambiguity are associated with genetic variation in SLC6A4.

AB - Decisions made under ambiguity may involve a different genetic architecture than those made under risk. Because gender moderates the effect of genetic polymorphisms on serotonin function and because there are gender differences in decision-making, the present study examined potential gender moderation of associations between polymorphisms in important serotonin system candidate genes (serotonin transporter [SLC6A4] and tryptophan hydroxylase-2 [TPH2]) and performance on a decision-making task (Iowa Gambling Task, IGT) in healthy, adults (N = 188; 62% women). Subjects were genotyped for the well-studied SLC6A4 promoter variant 5-HTTLPR and a TPH2 single nucleotide polymorphism in intron-8 (rs1386438). Genotype at rs1386438 was not associated with performance on the IGT. A significant gender by 5-HTTLPR genotype interaction effect was detected when decision-making was under ambiguity (i.e. the first block of 20 choices), but not under risk (blocks 2-5). Performance on the first block of 20 choices was not correlated with performance on subsequent blocks, supporting the interpretation that early performance on the IGT indexes decision-making under ambiguity, while performance on blocks 2-5 indexes decision-making under risk. These findings suggest that decision-making under ambiguity and risk may have different genetic architectures and that individual differences in decision-making under ambiguity are associated with genetic variation in SLC6A4.

KW - Decision-making

KW - Iowa gambling task

KW - Serotonin

UR - http://www.scopus.com/inward/record.url?scp=72049117362&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72049117362&partnerID=8YFLogxK

U2 - 10.1016/j.neuropharm.2009.09.010

DO - 10.1016/j.neuropharm.2009.09.010

M3 - Article

VL - 58

SP - 423

EP - 428

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 2

ER -